Response Oncology Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Response Oncology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Response Oncology over a specified time horizon. Remember, high Response Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Response Oncology's market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Response |
Response Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Response Oncology market risk premium is the additional return an investor will receive from holding Response Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Response Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Response Oncology's performance over market.| α | 0.00 | β | 0.00 |
Response Oncology Fundamentals Vs Peers
Comparing Response Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Response Oncology's direct or indirect competition across all of the common fundamentals between Response Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Response Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Response Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Response Oncology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Response Oncology to competition |
| Fundamentals | Response Oncology | Peer Average |
| Return On Equity | -7.24 | -0.31 |
| Return On Asset | -0.0153 | -0.14 |
| Profit Margin | (0.47) % | (1.27) % |
| Operating Margin | (0.01) % | (5.51) % |
| Current Valuation | 16.62 M | 16.62 B |
| Shares Outstanding | 12.18 M | 571.82 M |
| Revenue | 118.08 M | 9.43 B |
Response Oncology Opportunities
Response Oncology Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | ImmunoGen rockets on Elaheres practice-changing ovarian cancer ... - The Pharma Letter | 05/04/2023 |
About Response Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Response or other delisted stocks. Alpha measures the amount that position in Response Oncology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Response Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Response Oncology's short interest history, or implied volatility extrapolated from Response Oncology options trading.
Build Portfolio with Response Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Response Stock
If you are still planning to invest in Response Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Response Oncology's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |